By Anton Ladnyi, CFA · ex-Goldman Sachs · ex-J.P. MorganPublished Updated
AVGO — custom silicon franchise (recovering from -12-15% post-Q2 selloff from $481 ATH) — Q2 FY2026 record: $22.2B rev +48%, AI $10.8B +143%, FCF >$10B first time; AI rev to double H2 vs H1 (FY2026 on track $56B+); OpenAI 10GW collaboration, Meta 2029/2nm deal, Apollo/Blackstone $35B Anthropic platform; 6 hyperscaler customers confirmed; JPMorgan $580 PT (Jun 17); Macquarie downgrade (MediaTek TPU risk); dividend $0.65 ex-date Jun 22.
AVGO Price Target & Rating
AVGO's grade is Strong Buy, with moderate downside risk (CVaR -13.8%), and quality metrics (net margin 39%, ROE 37%). Broadcom Inc. (AVGO) trades at $411.35 with a valuation grade of Strong Buy: a trailing P/E of 68.2x at a 113% premium to sector median, net margins of 38.8%, a DCF-implied intrinsic range of $217–$609 suggesting a +0% margin of safety, beta 1.43 (moderate risk profile).
DCF Valuation Range
Key Takeaways
Valuation: Strong Buy grade — P/E 68.2x — DCF range $217–$609 implies +0% margin of safety
Risk: CVaR -13.8% (95th percentile, 1-month) indicates moderate tail exposure; beta of 1.43 amplifies broad market moves in both directions
Strengths: Quality 5.0/5, Size 5.0/5, 39% net margin, 37% ROE dominate the factor profile
Catalyst: Q3 FY2026 earnings ~September 2026 — AI revenue delivery vs $16B guide; H2 doubling of H1 AI revenue ($38.4B+) confirmation; disclosure of fifth or sixth hyperscaler ASIC program; dividend ex-date June 22; 2nm chip production milestones with Meta and Google
Bear catalyst: Q3 AI revenue misses $15B; MediaTek confirmed winning material Google TPU share in 2027 roadmap; software growth decelerates below 5% for two consecutive quarters; CEO qualifies $100B+ AI revenue timeline
Main riskP/E of 68.2x creates asymmetric downside on any earnings disappointment
Tail riskCVaR -13.8% over one month at the 95th percentile
DCF range$217–$609 intrinsic range; margin of safety +0%
Best useCore mega-cap Technology holding — not a source of diversified sector exposure
Next watchEarnings delivery consistency and margin trajectory
Quantitative Factor Profile
Value
2.0 / 5
Quality
5.0 / 5
Momentum
3.0 / 5
Volatility
2.5 / 5
Size
5.0 / 5
Key Metrics
AVGO Key Metrics — Broadcom Inc. 2026
Metric
Value
Current Price
$411.35
P/E Ratio (TTM)
68.2x
Forward P/E
21.3x
PEG Ratio
0.25x
P/S Ratio
25.9
EV/EBITDA
43.7
Beta
1.43
Net Margin
38.8%
ROE
37.3%
Debt/Equity
74.0%
Dividend Yield
0.69%
CVaR (95%, 1M)
-13.8%
Market Cap
$1.96T
Analyst View
Anton Ladnyi, CFA · A.L. Capital AdvisoryUpdated 2026-06-19
Rating Rationale
AVGO — custom silicon franchise (recovering from -12-15% post-Q2 selloff from $481 ATH) — Q2 FY2026 record: $22.2B rev +48%, AI $10.8B +143%, FCF >$10B first time; AI rev to double H2 vs H1 (FY2026 on track $56B+); OpenAI 10GW collaboration, Meta 2029/2nm deal, Apollo/Blackstone $35B Anthropic platform; 6 hyperscaler customers confirmed; JPMorgan $580 PT (Jun 17); Macquarie downgrade (MediaTek TPU risk); dividend $0.65 ex-date Jun 22.
Investment Thesis
↑ Bull Case
Q2 FY2026 AI semiconductor revenue $10.8B +143% YoY; FCF exceeded $10B in a single quarter for first time ever; net income $9.31B (+88%); profit margin 42% (up from 33%); Q3 FY2026 total revenue guide $29.4B (+84% YoY) ahead of $28.53B estimate
AI revenue to double H2 vs H1 per CEO Hock Tan: H1 AI = $19.2B → H2 implied ~$38.4B → FY2026 AI ~$57.6B (tracking above $56B guide); 6 confirmed hyperscaler customers: Anthropic, Google, Meta, OpenAI + 2 unnamed
OpenAI strategic collaboration: Broadcom develops and deploys 10 gigawatts of OpenAI-designed AI accelerators; all networking on Broadcom Ethernet — deepens hyperscaler lock-in and custom silicon moat
Meta partnership extended through 2029 including 2nm AI chips — ahead of NVIDIA on advanced node custom silicon; Apollo Global Management and Blackstone Credit $35B AI infrastructure financing platform for Anthropic expansion using Broadcom chips; Google Cloud TPU extended through 2031
JPMorgan (Harlan Sur) raised PT to $580 on June 17, called sell-off overdone, dismissed Google chip delay rumor; analyst consensus 48 analysts "Strong Buy," avg PT ~$522; Jefferies raised PT to $550 ($500), Mizuho to $530 ($480)
Dividend: $0.65/share, ex-date June 22, payable June 30; Tensordyne AI inference chip announced (Broadcom + TSMC); record operating margin 67% and adjusted EBITDA 69% — custom silicon leverage compounding
↓ Bear Case
Q3 AI chip guidance $16B trailed $17.2B analyst estimate — first AI guidance miss vs buy-side expectations; stock fell 12-15% from $481 ATH to low $380s post-earnings despite record results; recovered to ~$411 but full multiple re-rating may be delayed
CEO Hock Tan reiterated AI revenue "in excess of $100B" (longer-term target) but did NOT raise near-term FY2026 guide — disappointed investors expecting upward revision; signals potential demand ceiling awareness
Macquarie downgraded to Neutral (PT $437) citing Google TPU market share risk: Broadcom share could fall from ~95% in 2026 to ~65% in 2028 as MediaTek gains ground — customer concentration in 2-3 custom silicon programs materializing as a risk
Software segment $7.2B growing only 9% YoY — VMware pricing cycle maturing; SaaS conversion slower than modeled; no guidance raise disappoints given slight revenue miss vs $22.27B estimate
At ~30x forward earnings post-selloff recovery, meaningful multiple compression risk if AI revenue growth decelerates below 100% YoY; hyperscaler AI ASIC competition intensifying from Marvell
What Changes the Rating
↑Catalyst:Q3 AI revenue confirms $16B+ and full-year AI guide raised above $60B; fifth confirmed hyperscaler ASIC program disclosed; FCF sustains above $10B per quarter demonstrating margin leverage at scale
↓Stop / exit:Q3 AI revenue misses $15B; MediaTek confirmed winning material Google TPU share in 2027 roadmap; software growth decelerates below 5% for two consecutive quarters; CEO qualifies $100B+ AI revenue timeline
Anton’s personal note
AVGO is the kind of name I want to own more of, not less. The factor combination is genuinely constructive. What I watch on this name is earnings consistency — specifically whether delivery against consensus is stable or deteriorating. That is usually where the rating gets confirmed or challenged before the price reflects it. The setup that would make me more positive is a quarter that confirms the operating leverage story. The setup that would make me cautious is any signal that consensus estimates are getting ahead of fundamentals.
— Anton Ladnyi, CFA
Earnings History
AVGO Earnings History — EPS Surprise Rate 2026
Quarter
EPS Est.
EPS Actual
Surprise
Q2 2026
$2.40
$2.44
+1.7% ✓
Q1 2026
$2.02
$2.05
+1.3% ✓
Q4 2025
$1.87
$1.95
+4.4% ✓
Q3 2025
$1.66
$1.69
+1.6% ✓
Quarterly EPS — Estimate vs Actual
Earnings Projections
AVGO Forward EPS Consensus Estimates 2026
Quarter
EPS Est.
YoY EPS
Analysts
Q3 2026
$3.24
+91.7%
37
Q4 2026
$3.87
+98.7%
35
Q1 2027
~$2.60
+26.8%
42
Q2 2027
~$4.85
+98.8%
44
~ Estimated from annual consensus — not a direct analyst survey
AVGO — P/E 68.2x · Beta 1.43 • Quantitative grade: Buy • CVaR from one-year daily history · historical simulation
DCF Scenario Analysis
Hover each scenario for detail · current price $411.35
▼
Bear Case
$200
-51.4%
Fwd P/E: 13.7x
12% revenue CAGR · 20x exit multiple
◆
Base Case
$470
+14.3%
Fwd P/E: 32.3x
28% revenue CAGR · 30x exit multiple
▲
Bull Case
$720
+75.0%
Fwd P/E: 49.4x
40% revenue CAGR · 40x exit multiple
Pairwise Correlation Matrix
0 of 10 peer pairs correlated above 0.60 — diversification benefit within this cluster is structurally limited.
Extended Analysis — Buy, Hold or Sell? Risk Factors. Portfolio Fit.
Is AVGO a buy, hold, or sell?
AVGO carries a valuation grade of Strong Strong Buy. The trailing P/E of 68.2 sits 113% above the Technology sector median of 32.0x — a premium that demands sustained earnings delivery. Our discounted cash flow model produces an intrinsic range of $217–$609 — implying a +0% margin of safety at the current price of $411.35. The width of the DCF range reflects genuine uncertainty in the terminal growth rate assumption: the correct framework is a probability-weighted distribution over scenarios, not a single point estimate. See the DCF valuation framework for full methodology.
With a 12% beat rate on recent quarters, earnings predictability has been mixed. Analyst estimate revisions are trending upward.
What are AVGO's key risk factors?
With a beta of 1.43, AVGO exhibits an above-market risk profile relative to the broad market. The 95th-percentile CVaR of -13.8% on a one-month horizon should inform position sizing directly: at a 10% portfolio weight, this tail event contributes approximately 1.4% of total portfolio loss in the worst 5% of months. Net margins of 38.8% are significantly above the Technology sector average of 22%, reflecting durable pricing power. Return on equity of 37.3% indicates highly efficient capital allocation. The balance sheet is conservatively leveraged at 74% debt-to-equity.
Insiders have been net sellers to the tune of $1250.6M recently. While routine dispositions are common, the magnitude bears watching. Short interest is low at 1.2% of float, suggesting limited bearish conviction.
How does AVGO fit in a diversified portfolio?
At typical HENRY portfolio weights — 10–20% of the equity allocation — AVGO carries a beta of 1.43, meaning it amplifies broad market moves proportionally. The appropriate weight is not a function of conviction alone, but of the full covariance structure across all holdings. See the Ledoit-Wolf covariance framework for the methodology behind these calculations.
Among closely correlated names, AVGO shows the strongest co-movement with NVDA (0.51), MRVL (0.45), ADI (0.33). Investors seeking diversification should note these correlation dynamics when constructing multi-asset portfolios.
True portfolio risk is a function of the full covariance structure across all holdings — not individual stock metrics. The Portfolio Health Check quantifies this at the portfolio level: it surfaces hidden concentration, marginal CVaR contributions, and the degree to which your overall allocation deviates from an optimal risk-adjusted mandate. The AVGO analysis here is a single node in that larger structure.
Broadcom Inc. (AVGO) carries a Strong Buy quantitative rating from A.L. Capital Advisory, derived from Discounted Cash Flow intrinsic value analysis, five-factor model scoring (Value, Quality, Momentum, Volatility, Size), and CVaR tail risk measurement. At $411.35, the DCF midpoint margin of safety is +0% (intrinsic value range: $217 bear – $609 bull). Composite factor score: 3.5/5. Strongest factor: Quality (5.0/5). Weakest factor: Value (2.0/5). Trailing P/E: 68.2x. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Portfolio Construction Framework →
What is the average analyst target price for AVGO?
Wall Street consensus target for AVGO: $523.84 (+27.3% upside from the current price of $411.35). The analyst target range spans $215.88 (most bearish) to $650.00 (most bullish). Consensus recommendation: Strong Buy. Note that analyst price targets typically reflect a 12-month forward horizon and are derived from a blend of DCF, comparable-company, and sum-of-the-parts analysis. A.L. Capital Advisory’s quantitative Strong Buy rating is produced independently — from DCF intrinsic value, five-factor model scores, and CVaR tail risk — and does not mechanically track Street consensus. When the two diverge, the divergence itself is informative: it can reflect differences in time horizon, valuation methodology, or the degree to which the current price already discounts the consensus case. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Monte Carlo Simulation Framework →
How does AVGO score on Value, Quality, Momentum, Volatility, and Size?
AVGO five-factor scores (A.L. Capital Advisory, 1–5 scale): Value 2.0/5 (below average) — measures current price versus DCF intrinsic range and trailing earnings multiples; Quality 5.0/5 (strong) — captures profitability metrics including return on equity, net margin (ROE: 37.3%) and net margin (38.8%); Momentum 3.0/5 (neutral) — reflects recent price trajectory and earnings surprise consistency; Volatility 2.5/5 (neutral) — inverse measure derived from beta, where lower historical volatility earns a higher score; Size 5.0/5 (strong) — market capitalisation rank (mega-cap $1T+ scores 5/5). Composite: 3.5/5. Factor scores above 4.0 signal a tailwind in that dimension; below 2.0 signals a material headwind. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Black-Litterman Model →
What is AVGO's tail risk and CVaR?
The 95th-percentile Conditional Value at Risk (CVaR) for AVGO on a one-month horizon is -13.8%. CVaR represents the expected average loss in the worst 5% of monthly outcomes — a more conservative tail risk measure than standard VaR, which only marks the loss threshold. Beta of 1.43 indicates above-market volatility with amplified drawdown exposure. For reference, a diversified S&P 500 ETF carries a one-month CVaR of roughly -8% to -12% in normal market conditions; individual equity CVaR is higher due to idiosyncratic risk. At the portfolio level, what matters is the marginal CVaR contribution of each holding — not its standalone figure. The A.L. Capital Advisory Portfolio Health Check quantifies each position's marginal tail-risk contribution across your entire holdings. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: CVaR & Tail-Risk Methodology →
What is AVGO's intrinsic value and DCF price target?
A.L. Capital Advisory's DCF model produces an intrinsic value range of $217 (bear case) to $609 (bull case) for Broadcom Inc. (AVGO). At $411.35, the midpoint margin of safety is +0% (positive = discount to intrinsic mid; negative = premium). The bear-to-bull spread reflects genuine sensitivity to the two dominant DCF inputs: the terminal growth rate and WACC. Terminal value typically accounts for 60-80% of total intrinsic value in most equity DCF models, which is why a range is more analytically sound than a point estimate. The central analytical question is not what the DCF outputs as a single number but which growth trajectory the current market price already discounts. All DCF analysis follows CFA Institute standards and is conducted by Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: DCF Valuation Framework →
What would trigger a rating upgrade or downgrade for AVGO?
Upgrade trigger: Upgrade to Strong Buy on evidence of accelerating earnings surprise magnitude combined with improvement in the Value factor score — specifically if the current 68.2x P/E is supported by an upward revision to DCF terminal growth assumptions. Downgrade trigger: An earnings miss at current valuations (68.2x trailing P/E) where there is limited earnings cushion to absorb negative surprises; or a sustained reversal in the Quality and Momentum factor scores for two or more consecutive quarters. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Investment Policy Statement Framework →
How does AVGO contribute to portfolio risk and diversification?
AVGO carries a beta of 1.43 (high-volatility / growth-sensitive relative to the broad equity market). A beta above 1.0 means the position amplifies market moves in both directions at a typical portfolio weight. Strongest peer co-movement: NVDA (0.51), MRVL (0.45), ADI (0.33). Holding AVGO alongside these names in the same portfolio increases concentration risk. True portfolio risk is a function of the full covariance structure — a single stock's beta does not reveal its marginal contribution to portfolio tail loss. The A.L. Capital Advisory Portfolio Health Check quantifies concentration risk (Herfindahl-Hirschman Index), pairwise correlations, and marginal CVaR contribution across all your holdings. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Ledoit-Wolf Covariance Framework →
What quantitative methodology does A.L. Capital Advisory use to analyse AVGO?
A.L. Capital Advisory analyses Broadcom Inc. (AVGO) using a four-component quantitative framework grounded in CFA Institute standards. (1) DCF Valuation: projects free cash flows under bear and bull assumptions, discounts at WACC to produce an intrinsic value range with margin-of-safety calculation. (2) Five-Factor Scoring: each equity is scored 1–5 on Value, Quality, Momentum, Volatility, and Size. (3) CVaR Tail Risk: 95th-percentile Conditional Value at Risk from historical simulation of daily returns on a one-month horizon. (4) Earnings Surprise Analysis: quarterly beat rate and magnitude are incorporated into the Momentum and Quality factor scores. The current Strong Buy rating for AVGO is the output of applying this complete framework to current data. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: DCF Valuation Framework → · CVaR & Tail-Risk Methodology →
Stress-Test This View Live
Run AVGO in Asset Lens
Live DCF valuation, Monte Carlo simulation, options flow intelligence, and full factor decomposition — updated in real time. Free, no account required.
This analysis is produced using a systematic quantitative framework applied to market data and does not constitute investment advice. Prose commentary is AI-assisted and generated from structured quantitative inputs. All data and metrics are as of 2026-06-19 and are point-in-time estimates subject to revision without notice. CVaR figures are based on historical simulation and do not guarantee future outcomes. DCF ranges and upgrade/downgrade triggers are forward-looking statements based on current assumptions and may not materialise. Past performance does not guarantee future results. This analysis does not account for individual circumstances, tax position, or investment objectives — consult a qualified financial advisor before making investment decisions. This content is intended for informational purposes only and does not constitute regulated investment advice under MiFID II or FCA guidelines. This content is not intended for US persons or residents of jurisdictions where its distribution would be contrary to local law or regulation. This service is not directed at residents of Finland, Sweden, Norway, Denmark, Iceland, or Poland. The author may hold long or short positions in securities mentioned in this analysis. Nothing on this page represents a solicitation to buy or sell any security. A.L. Capital Advisory is an independent private advisory practice and is not affiliated with Broadcom Inc.
CFA Portfolio Advisory — AVGO
Discuss this analysis, position sizing, or your full portfolio mandate with Anton Ladnyi, CFA.
